What Is Mifepristone, the Abortion Drug at Issue in the Hearing?
A key issue in the hearing has been whether Robert F. Kennedy Jr. would increase scrutiny of the abortion drug mifepristone if he becomes HHS secretary. The drug is part of a two-step process that is now the most common way to end a pregnancy in the U.
Last Friday, my colleague Julianne McShane and I broke the news of a pair of letters sent by 30 prominent anti-abortion ...
A new study shows a possible new abortion drug to replace mifepristone. But will these results increase abortion access—or restrict women's reproductive health options down the line?
A higher dose of an emergency-contraception drug may open a back door for Americans seeking abortions in restrictive states.
Efforts to limit access to mifepristone have received a boost from a federal judge who took the bench during Trump's first term.
The three states argue that the FDA's approval of mifepristone for use up to 10 weeks of pregnancy, along with its availability via telemedicine and mail, has contributed to what they view as a public ...
Meanwhile, in an executive order, Trump created his long-discussed “Department of Government Efficiency,” to be led by Elon ...
Robert F. Kennedy Jr. suggested, if confirmed to head the Department of Health and Human Services, he is open to ...
Robert F. Kennedy Jr.’s alternating views on vaccines, reproductive rights and public health issues were a central focus at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback